Introduction
DNA double-strand breaks (DSBs) are generated when the phosphodiester backbones of both DNA strands are broken at the same position or in sufficient proximity to allow physical dissociation of the double helix into 2 separate molecules (1) . DSBs can be induced by ionizing radiation, chemotherapeutic drugs, oxidative stress, and replication fork collapse (2) . Inappropriate repair of DSBs may result in propagation of deleterious mutations, genomic instability, immune deficiency, cancer predisposition, and accelerated aging or cell death (3) (4) (5) .
Cells utilize 2 major pathways for DSB repair: nonhomologous end joining (NHEJ) and homologous recombination (HR). NHEJ facilitates DSB repair by direct ligation of broken DNA ends (6) . To initiate NHEJ, the Ku70/Ku80 heterodimer binds to blunt or near-blunt DNA ends. DSB-bound Ku then recruits and activates the DNA-dependent protein kinase catalytic subunit (DNA-PKcs), which triggers a signaling cascade that orchestrates downstream repair processes that eventually seal the breaks (7) . In the HR repair pathway, DSBs are recognized by the MRN (Mre11-Rad50-NBS1) complex and CtIP to initiate DSB end resection leading to generation of 3′ single-stranded DNA (ssDNA) overhangs through endonucleolytic cleavage followed by 3′-5′ exonucleolytic processing (6, 8, 9) . The 3′ ssDNA overhangs are initially coated by the RPA complex to form an RPA-ssDNA nucleoprotein filament to allow extensive resection by the EXO and DNA2 nucleases, followed by displacement of RPA to allow assembly of the Rad51-ssDNA nucleoprotein filament (1) . Rad51 loading promotes invasion onto the undamaged template and strand displacement, generating D-loop formation, which is necessary to generate a Holliday junction and a heteroduplex molecule. Repair ensues using the undamaged strand as a template, followed by ligation of the DNA ends (10) .
The proper choice of DSB repair pathway has a profound impact on genomic integrity and the prevention of cancer (1) . DSB repair via HR ensures fidelity and reduces the probability of mutation or genomic instability compared with NHEJ, because HR uses an undamaged template with homologous sequences to restore sequence information lost at the DSB site, whereas NHEJ does not require sequence homology for repair (1, 10) . The choice between these pathways depends on the phase of the cell cycle and the nature of the DSB ends (11) . NHEJ is active throughout all phases of the cell cycle but predominates in G 1 . HR is more active in S and G 2 phases during DNA replication, since an identical sister chromatid is available as a template for repair (6, 12) . A major restriction point in the choice between DSB repair pathways is the competition between Ku-mediated DNA end protection and MRN complex-initiated DNA end resection (13, 14) . For example, initiation of 5′-3′ resection of DNA ends by the MRN complex commits cells to HR-dependent repair, and prevents repair by classical NHEJ. Once HR is initiated, NHEJ cannot be utilized in most instances. Conversely, once Ku binds dsDNA ends with high affinity, the DSB-bound Ku complex restricts the ability of the MRN complex to initiate DNA resection, which suppresses HR, while, at the same time, promoting NHEJ (1, 10, 15) . A major, unanswered question is how MRN directly or indirectly counteracts NHEJ to promote HR. One possibility is that there is a pathway choice con-DNA double-strand breaks (DSBs) are mainly repaired either by homologous recombination (HR) or by nonhomologous end-joining (NHEJ) pathways. Here, we showed that myeloid cell leukemia sequence 1 (Mcl-1) acts as a functional switch in selecting between HR and NHEJ pathways. Mcl-1 was cell cycle-regulated during HR, with its expression peaking in S/G 2 phase. While endogenous Mcl-1 depletion reduced HR and enhanced NHEJ, Mcl-1 overexpression resulted in a net increase in HR over NHEJ. Mcl-1 directly interacted with the dimeric Ku protein complex via its Bcl-2 homology 1 and 3 (BH1 and BH3) domains, which are required for Mcl-1 to inhibit Ku-mediated NHEJ. Mcl-1 also promoted DNA resection mediated by the Mre11 complex and HR-dependent DSB repair. Using the Mcl-1 BH1 domain as a docking site, we identified a small molecule, MI-223, that directly bound to BH1 and blocked Mcl-1-stimulated HR DNA repair, leading to sensitization of cancer cells to hydroxyurea-or olaparib-induced DNA replication stress. Combined treatment with MI-223 and hydroxyurea or olaparib exhibited a strong synergy against lung cancer in vivo. This mechanism-driven combination of agents provides a highly attractive therapeutic strategy to improve lung cancer outcomes.
Targeting Mcl-1 enhances DNA replication stress sensitivity to cancer therapy repair and reinitiation of stalled DNA replication forks, leading to sensitization of cells to radiation (24) .
Here we report the discovery that, during cell cycle progression, Mcl-1 peaks and selectively interacts with Ku in S/G 2 phase, resulting in the suppression of NHEJ while simultaneously promoting DNA resection and activation of the HR pathway. This indicates that Mcl-1, in addition to its antiapoptotic function, also functions in mediating DSB repair pathway choice. Following our identification of this mechanism, we have discovered a novel small molecule, MI-223, that disrupts the Mcl-1/Ku interaction, inhibits HR activity, and strongly synergizes with DNA replication stress agents (hydroxyurea or olaparib) against lung cancer in vitro and in vivo.
Results

Mcl-1 accumulates in S/G 2 -phase cells.
Mcl-1 is primarily localized in the outer mitochondrial membrane and in small quantities in the nucleus (16) . To determine whether the cell cycle affects Mcl-1 expression and subcellular localization, we used the cell cycle markers CENP-F and cyclin A, which are absent in G 1 phase and active during S and G 2 phases (25, 26) . Significantly increased levels of cytoplasmic and nuclear Mcl-1 were observed in S/G 2 phase compared with G 1 phase in H1299 human lung cancer cells ( Figure 1A ). The specificity of Mcl-1 antibody used in this expertroller that allows NHEJ to predominate in G 0 /G 1 and subsequently switch to the HR pathway in S/G 2 during cell cycle progression through regulation of the core DSB repair machinery.
Myeloid cell leukemia sequence 1 (Mcl-1) is a unique antiapoptotic Bcl-2 family member that is overexpressed in many tumor types (16, 17) . Mcl-1 expression is tightly regulated at multiple levels, including transcriptional, posttranscriptional, and posttranslational processes (18) . In contrast to other antiapoptotic Bcl-2 family members (i.e., Bcl-2, Bcl-xL, Bcl-w, and Bfl-1A1), Mcl-1 has a considerably longer N-terminus that is intrinsically unstructured and therefore resistant to structural analyses (19) . Mcl-1 is unique with respect to its short half-life (30 minutes to 3 hours) and short-term prosurvival function, which probably relates to the presence of a long proline-, glutamic acid-, serine-, and threonine-rich (PEST) region upstream of the Bcl-2 homology (BH) domain (17) . Mcl-1 expression changes rapidly in response to cellular stresses or cell cycle progression, because its degradation is tightly regulated by three E3 ligases (Mule, FBW7, and β-TrCP) and two deubiquitinases (USP9X and Ku70) (17, 19, 20) . In addition to its cell survival function, Mcl-1 has been demonstrated to regulate ATR-mediated CHK1 phosphorylation and localize to sites of DNA damage in response to DNA damage (21) (22) (23) of γ-H2AX foci per cell were determined as described previously (31) . Knockout of Mcl-1 significantly delayed the disappearance of γ-H2AX foci following DNA replication stress ( Figure 2 , A and C). Because the repair of DNA replication stress-induced DSBs occurs through the HR DNA repair pathway (6), our results indicate a potential role for Mcl-1 in HR-dependent DSB repair, which is consistent with and/or extends recent findings from others (24) . These data indicate that slower repair of Hu-induced DSBs in Mcl-1-deficient cells may result from inhibition of the HR repair pathway. The repair of x-ray-induced DSBs occurs mainly through the NHEJ pathway (10) . Mcl-1 loss did not delay γ-H2AX disappearance and even slightly promoted the repair of x-ray radiation-induced DSB foci (Supplemental Figure 3) . Collectively, these results indicate that Mcl-1 differentially regulates HR and NHEJ DNA repair pathways.
To better examine the effects of Mcl-1 on the rate of DNA repair and HR efficiency, endogenous Mcl-1 was knocked out from H1299 cells using the CRISPR/Cas9 system ( Figure 3A ).
H1299 parental and H1299 Mcl1
-/-cells were treated with irradiation (IR) (0.5 Gy), followed by costaining with cyclin A and γ-H2AX antibodies. IR induced clear γ-H2AX foci formation in both H1299 parental and H1299
Mcl1
-/-cells ( Figure 3B , left panel). By 7 hours after radiation, the majority of γ-H2AX foci had disappeared in H1299 parental cells, including cells in both S/G 2 (i.e., cyclin A positive) and G 1 (i.e., cyclin A negative) phases ( Figure 3B , right panel), indicating that most DSBs were repaired. However, significantly more γ-H2AX foci were observed in the S/G 2 but not the G 1 population in H1299 Mcl1 -/-cells by 7 hours after radiation ( Figure 3B , right panel), indicating that Mcl-1 is essential for efficient DSB repair in S/G 2 -phase but not G 1 -phase cells. The formation of Rad51 foci is considered a marker of HR DNA repair (32, 33) . Rad51 foci were compared in H1299 parental and H1299
-/-cells following IR treatment. Rad51 foci were mainly observed in the S/G 2 (cyclin A positive) population of H1299 parental cells after IR. Rad51 foci were significantly decreased in S/G 2 cells in which Mcl-1 was knocked out following IR ( Figure 3C ). These findings provide additional evidence that Mcl-1 is required for HR repair in S/G 2 cells.
To test whether Mcl-1 loss sensitizes cells to DNA replication stress, WT and Mcl1 -/-MEFs were treated with increasing doses of Hu, which is known to induce cell killing via DNA replication stress (34) . Clonogenic survival assays revealed that knockout of Mcl-1 significantly enhanced Hu-induced cell killing (Supplemental Figure 4A) . Furthermore, Mcl-1 was knocked down using Mcl-1 shRNA or knocked out using CRISPR/Cas9 from H1299 cells, followed by treatment with Hu or the PARP inhibitor olaparib (35) . Disruption of Mcl-1 significantly sensitized H1299 cells to the DNA replication stress agents Hu and olaparib (Supplemental Figure 4 , B and C).
Mcl-1 enhances HR and suppresses NHEJ. An HR reporter plasmid (pDR-GFP) that contains a GFP gene inactivated by insertion of the I-SceI endonuclease recognition site was used to measure HR activity ( Figure 4A , left panel, and ref. 36) . Active GFP can be restored only after I-SceI-induced DSB is repaired by HR. We observed a significant reduction in HR activity in Mcl1 -/-MEFs compared with WT MEFs ( Figure 4B ). To provide a more physiologically relevant test of HR efficiency, U2OS DR-GFP cells carrying a chromosomally integrated single copy of the GFP HR iment was further confirmed as shown in Supplemental Figure 1 (supplemental material available online with this article; https:// doi.org/10.1172/JCI92742DS1. See complete unedited blots in the supplemental material). To verify the S/G 2 -specific nature of Mcl-1 accumulation, H1299 cells were synchronized at the G 1 /S boundary by double-thymidine block, followed by release into the cell cycle. Most cells entered S phase at 2 hours, reached G 2 phase around 8 hours, and returned to G 1 phase at 14 hours (Supplemental Figure 2A ). Mcl-1 protein but not mRNA levels gradually increased from 2 hours and returned to a baseline level after 14 hours (Figure 1, B-D) . As expected, cyclin A (an S/G 2 marker) and cyclin F (a late G 2 marker) were expressed in a cell cycledependent manner. In contrast, both protein and mRNA levels of Bcl-2 and Bcl-xL were not significantly changed during cell cycle progression (Figure 1 Figure 1E ). Subcellular fractionation experiments revealed that Mcl-1 levels in both isolated mitochondria and nuclear fractions were significantly enhanced in S-phase (2 hours) and G 2 -phase (8 hours) cells ( Figure 1F ). These findings suggest that specific upregulation of Mcl-1 in S/G 2 may play a role distinct from its antiapoptotic function.
Mcl-1 is required for HR-dependent DSB repair and clonogenic survival following DNA replication stress. Hydroxyurea (Hu) is an inhibitor of ribonucleotide reductase, an enzyme essential for de novo deoxyribonucleotide triphosphate (dNTP) synthesis (27) . Hu depletes cells of dNTPs, leading to DNA replication stress, which initially results in stalled replication forks that, after prolonged treatment, collapse into DSBs (28) . To test whether Mcl-1 affects the repair of DNA replication stress-induced DSBs, WT and Mcl1 -/-mouse embryonic fibroblasts (MEFs) were subjected to Hu (0.2 mM) treatment for 24 hours. Following Hu removal, cells were incubated in normal culture medium for various times up to 24 hours. Hu-induced DSBs were assessed by pulsed-field gel electrophoresis (a direct method for the measurement of DSBs) as previously described (29) . Tables 1 and 2 ).
reporter with I-SceI site were also used to measure HR activity (37, 38) . Accordingly, depletion of Mcl-1 from U2OS DR-GFP cells using Mcl-1 siRNA also significantly reduced HR efficiency (Figure 4C ). NHEJ activity was also compared in WT versus Mcl1
MEFs using the NHEJ substrate pGFP-Pem1-Ad2 system, in which the GFP sequence is interrupted by an inserted adenovirus exon 2 (Ad2) sequence (39) . Following removal of Ad2 by HindIII, active GFP can be restored in the resulting plasmid only through NHEJ repair ( Figure 4A , right panel). We found that NHEJ activity was increased in the absence of Mcl-1 ( Figure 4D ). These findings sug- -/-cells were treated with IR (0.5 Gy), followed by costaining with cyclin A and γ-H2AX antibodies immediately or after 7 hours. Cyclin A is a well-known S/G 2 marker; therefore, cyclin A-positive cells are considered as S/G 2 -phase cells. Scale bar: 25 μm. The γ-H2AX foci per cell were determined by counting of at least 100 cells from each sample. Data represent the mean ± SD, n = 3 per group. ***P < 0.001, by 2-tailed t test. (C) H1299 parental and H1299 Mcl1 -/-cells were treated with IR (0.5 Gy), followed by costaining with cyclin A and Rad51 antibodies. Scale bar: 25 μm. The Rad51 foci per cell were determined by counting of at least 100 cells from each sample. Data represent the mean ± SD, n = 3 per group. ***P < 0.001, by 2-tailed t test. jci.org
Volume 128 Number 1 January 2018
of Mcl-1 on Ku70 recruitment, and its positive effect on Mre11 recruitment following DSB induction, may be a critical factor for pathway choice in DSB repair.
Mcl-1 was enhanced in S/G 2 , but total levels of Ku70/Ku80 and Mre11 did not change during cell cycle progression (Supplemental Figure 7D ). To test whether Mcl-1 associates with factors regulating NHEJ and HR, coimmunoprecipitation (co-IP) was performed in H1299 cells during cell cycle progression. Mcl-1 selectively interacted with Ku70/Ku80 but not Mre11, peaking at S/G 2 phase (Supplemental Figure 7E) . To further assess whether cell cycle progression affects subcellular localization of Mcl-1 and Ku, first, G 1 -and S/G 2 -phase H1299 cells were isolated from double-thymidine block synchronization. Subcellular fractionation experiments were then performed to isolate heavy membrane-containing mitochondria, light membrane-containing endoplasmic reticulum, and nuclear (Nuc) fractions from G 1 -or S/G 2 -phase H1299 cells as we previously described (17) . Levels of Ku70 and Mcl-1 in each fraction were quantified from Western blot by ImageJ software (NIH). In G 1 -phase cells, the majority of Mcl-1 (86%) was localized in mitochondria and only a small portion of Mcl-1 was localized in the endoplasmic reticulum (8%) and nucleus (6%), while Ku70 and Ku80 were localized only in the nucleus (Supplemental Figure  7F ). When cells entered S/G 2 phase, the distribution of Mcl-1 in the nuclear fraction was significantly enhanced (i.e., from 6% to 40%) (Supplemental Figure 7F) , thus having great potential to colocalize and/or interact with Ku proteins in the nucleus.
To test whether replication stress affects the Mcl-1/Ku interaction, time course experiments were carried out. -/-MEFs, followed by co-IP using a FLAG antibody. Similarly, deletion of the BH1 or BH3 domain resulted in loss of Mcl-1's ability to interact with Ku proteins in cells ( Figure 5C ).
Since Mcl-1 selectively binds to Ku but not Mre11 (Supplemental Figure 7E ), the effect of Mcl-1 on Ku-DNA binding or Mre11-DNA binding was compared by EMSA. Recombinant human Mre11-Rad50 (MR) complex was expressed and purified from baculovirus-infected Sf9 insect cells as previously described (42) ( Figure 5D ). As previously reported (43), Ku70/Ku80 heterodimer displayed binding to a 32 P-labeled, 3′ overhang DNA substrate with high affinity, while the MR complex displayed low binding affinity ( Figure 5E, lane 3 vs. lane 7) . Addition of purified Mcl-1 suppressed Mcl-1 molecules can be recruited to DSB sites following DNA DSBs. To address how Mcl-1 has the capacity to inhibit Ku even when there are relatively low levels of Mcl-1 in the nucleus, we first assessed whether Mcl-1 can be recruited to DNA DSBs. I-SceI was transfected into U2OS DR-GFP cells to induce DSBs, followed by ChIP using Mcl-1 antibody and PCR to detect DR-GFP break DNA fragment. Results indicated that Mcl-1 was associated with I-SceIinduced DSBs (Supplemental Figure 12A) . To further test whether Mcl-1 could be recruited to DSB sites following radiation, S/G 2 -phase H1299 cells harvested at 6 hours after double-thymidine block were exposed to IR (5 Gy), followed by costaining with Mcl-1 and γ-H2AX. Intriguingly, Mcl-1 molecules were mainly enriched on DSB sites to form foci and colocalized with γ-H2AX (i.e., a classic DSB marker) (Supplemental Figure 12B) Figure 13A ). Results revealed that knockout of endogenous Mcl-1 resulted in downregulation of HR activity and upregulation of NHEJ activity (Supplemental Figure 13 , B and C, panel 1 vs. panel 2). Intriguingly, expression of exogenous WT, ΔN, ΔPEST, ΔBH2, and ΔTM, but not ΔBH1 and ΔBH3, Mcl-1 mutants restored HR and suppressed NHEJ activity (Supplemental Figure 13 , B and C), but did not significantly affect the percentage of cells in S and G 2 phases of the cell cycle or the proliferation rate (Supplemental Figure 13, D-F To test whether inhibition of HR by MI-223 sensitizes cancer cells to DNA replication stress, H1299 cells were treated with olaparib or Hu in the absence or presence of MI-223, followed by analysis of Rad51 foci and clonogenic survival. Olaparib or Hu induced Rad51 foci and MI-223 strongly inhibited Rad51 foci formation ( Figure 8G and Supplemental Figure 16E ), suggesting that MI-223 suppresses HR-dependent DNA repair. Importantly, MI-223 suppression of HR DNA repair activity synergizes with olaparib or Hu to kill H1299 lung cancer cells ( Figure 8H and Supplemental Figure 16F ). Annexin V binding assays revealed that MI-223 did not induce significant apoptotic cell death (Supplemental Figure 16G ), indicating that MI-223-induced cell killing occurs mainly through suppression of Mcl-1-enhanced HR DNA repair activity, which occurs independently of apoptosis.
To further test whether MI-223 and DNA replication stress agents synergistically inhibit cancer growth in vivo, nude mice with non-small cell lung carcinoma (i.e., H1299) xenografts were treated with MI-223 (40 mg/kg/d), olaparib (40 mg/kg/d), Hu (500 mg/kg), and the combination of MI-223 with olaparib or Hu for 3 weeks. Importantly, the combination of MI-223 with olaparib or Hu exhibited significantly greater efficacy than a single agent alone in suppressing lung tumor growth in vivo ( Figure 9 , A and C), leading to sustained tumor repression. Compared with olaparib or Hu alone, there was significant reduction of Ki-67 in association with increased levels of γ-H2AX in tumor tissues from animals treated with the combination (Figure 9 , B and D), indicating that MI-223 blocks the HR-dependent repair of olaparib-or Huinduced DNA damage, leading to increased cell killing in tumor tissue. There was no significant weight loss, increase in alanine transaminase, aspartate transaminase, or blood urea nitrogen, nor reduction in wbcs, rbcs, hemoglobin, or platelets, in mice treated with MI-223 alone or in combination with olaparib or Hu. Histopathologic evaluation of harvested normal tissues (brain, heart, lung, liver, spleen, kidney, and intestine) revealed no evidence of normal tissue toxicity (Supplemental Figure 17) .
Discussion
Competition between NHEJ and HR, which stems from the molecular interplay between Ku and the Mre11 complex at DSB ends, decides the choice of DSB repair (1) . The first control point for this pathway choice is the process of DNA resection. Multiple proteins or protein complexes influence the HR/NHEJ pathway choice by regulating DNA end resection directly or indirectly, including the MRN complex, CtIP, EXO1, BLM, DNA2, BRAC1, 53BP1, RIF1, al experiments were carried out following treatment of cells with Hu or staurosporine. Expression of Nuc-WT but not Nuc-ΔBH1 or Nuc-ΔBH3 mutant Mcl-1 prolonged clonogenic cell survival after Hu treatment but had no effect following staurosporine exposure (Supplemental Figure 15, (Figure 7 and Supplemental Figures 14 and 15 ), indicating that BH1 or BH3 is an attractive target for screening small molecules to interfere with HR DNA repair and potentially sensitize cancer cells to DNA replication stress. A National Cancer Institute (NCI) database library of 300,000 small molecules was docked into the Mcl-1 BH1 structure pocket (aa 256-265) identified by the UCSF DOCK 6.1 program suite for a first round of screening as we previously described (ref. 48 and Figure 8A ). The small molecules were ranked according to their energy scores. The top 500 small molecules were then selected for a second round of screening by thermal shift binding assay using Mcl-1 protein (49) Domain-mapping studies reveal that Mcl-1 directly interacts with the Ku70/Ku80 dimer via its BH1 and BH3 domains. Importantly, these 2 Ku binding sites on Mcl-1 are essential not only for its inhibitory effect on NHEJ but also for its positive effects on DNA end resection and HR-mediated DSB repair, which reveals the mechanism of action of Mcl-1 in directing DSB repair pathway choice and increasing clonogenic survival following treatment with DNA replication stress agents.
Inhibition of apoptosis by Mcl-1 occurs through its heterodimerization with multiple proapoptotic Bcl-2 family proteins (i.e., Bim, Bak, or Bax) within the mitochondrial membranes (62) . In addition to this well-characterized antiapoptotic mechanism, we have discovered that Mcl-1 not only regulates the choice between HR and NHEJ, but also supports clonogenic cell survival through promotion of HR-dependent DSB repair following Hu-or olaparib-induced DNA replication stress. This activity could also contribute to therapeutic resistance in human cancers.
In addition to its mitochondrial localization, Mcl-1 has also been shown to be localized in the nucleus (21, 63) with levels peaking in S/G 2 . The exact role of nuclear Mcl-1 remains unclear. We have shown that selective expression of Mcl-1 in the nucleus facilitates HR-dependent DSB repair leading to increased clonogenic survival following DNA replication stress-induced DSBs. However, nuclear Mcl-1 does not have an antiapoptotic function, as evidenced by the inability of the nuclear-targeted Mcl-1 to support survival following treatment with the apoptotic agent staurosporine. We propose that nuclear Mcl-1 promotes HR-dependent DSB repair while mitochondrial Mcl-1 may inhibit apoptosis.
Using the NCI small-molecule library and the UCSF DOCK 6.1 screen program, we identified MI-223 as a lead compound that directly binds to Mcl-1 protein via its BH1 domain and disrupts the interaction between Mcl-1 and Ku. MI-223 induces robust cancer cell killing via inhibition of HR-mediated DNA repair. Importantly, MI-223-mediated reduction of HR activity renders cancer cells highly sensitive to DNA replication stress agents (Hu or olaparib) . This observation helps to explain why the combination of MI-223 with Hu or olaparib displayed strong synergism against lung cancer in mouse xenografts.
In conclusion, our findings have demonstrated that Mcl-1 is directly involved in the regulation of NHEJ-and HR-mediated DNA repair pathway choice. Physiologic accumulation of Mcl-1 in S/G 2 phase renders a net increase of HR over NHEJ. Direct interaction of Mcl-1 with Ku via its BH1 and BH3 domains is required for Mcl-1 inhibition of Ku-DNA binding, promotion of Mre11 complex-mediated DNA resection, and enhancement of HR activity, resulting in HR-dependent DSB repair and increased cell survival. Therefore, Mcl-1, in addition to its antiapoptotic function, appears to be a driver of the mechanism utilized for choice of DSB repair pathway. Specifically targeting this novel function of Mcl-1 by using small molecules such as MI-223 represents a potentially new, effective strategy for cancer therapy.
Methods
Supplemental Methods are available online with this article (supplemental material available online with this article; https://doi. org/10.1172/JCI92742DS1).
CDKs, RNF138, chromatin remodeling factors, and others (14, (54) (55) (56) (57) . Initiation of DNA end resection by the MRN complex and CtIP removes Ku from DNA ends to generate ssDNA overhangs that not only inhibit NHEJ but also provide a platform to recruit proteins involved in HR repair (47) . DNA end resection is a 2-step process in which the MRN complex and CtIP are involved in the initial step, and EXO1 and DNA2-BLM are involved in the second step (54, 58) . CDKs promote these 2 steps in the process of DNA resection by phosphorylating CtIP, NBS1, or EXO1, respectively (14, 55) . Ku ubiquitination mediated by the E3 ligase RNF138 and subsequent degradation promote DNA resection (57) . Intriguingly, BRAC1 promotes, whereas RIF1 acts as the effector of 53BP1 to inhibit, DNA resection and HR (55, 56) .
Several issues remain, in particular how cell cycle phase influences pathway choice and repair outcome. A cell cycle activation step is required to initiate the process of DNA end resection, but the mechanism remains unclear (59). Mcl-1 has been reported to play an important role in DNA repair/DNA damage response (21, 23, 24) . However, the exact mechanism is not fully understood.
Here we have demonstrated that Mcl-1, in addition to its wellknown antiapoptotic function, plays an unexpected role in DSB repair pathway choice during cell cycle progression.
NHEJ, which does not require DNA sequence homology, is active throughout the cell cycle in vertebrate cells (60, 61) . In contrast, HR occurs largely during the S/G 2 phase of the cell cycle, when a replicated sister chromatid is present and can be used as a homologous template to copy and restore the missing DNA sequence on the damaged chromatid (1) . This indicates that cell cycle transition from G 1 to S/G 2 is a critical check point for switching the predominant DSB repair pathway from NHEJ to HR. We have demonstrated that Mcl-1 is a positive regulator of HR DNA repair, and that accumulation of Mcl-1 via reduction of its ubiquitination in S/G 2 may tip the balance toward HR, consistent with HR being restricted to S and G 2 phases of the cell cycle (47) . For example, Mcl-1 depletion by knockout or knockdown can change the balance of repair toward an increase in NHEJ. Conversely, Mcl-1 overexpression shifts the balance toward HR, suggesting that Mcl-1 is able to direct DSB repair pathway choice by altering the NHEJ/ HR ratio during cell cycle progression.
Because DNA end resection is considered a major control point between NHEJ and HR choice (47) , DSB end resection must be appropriately restricted to S/G 2 , as HR requires the presence of an intact sister chromatid to promote repair (6) . Cells favor DSB repair by NHEJ if the DNA ends are suitable for joining, while DNA resection is activated if joining fails, particularly when DNA ends are not suitable for NHEJ (1) . Since Mcl-1 molecules were recruited to DSB sites following the induction of DSBs by IR or I-SceI, this could provide potential for Mcl-1 to be involved in the process of DNA resection. Intriguingly, Mcl-1 facilitates Mre11 complex-mediated DNA resection in a mechanism involving inhibition of Ku/DSB binding via direct interaction with Ku proteins, suggesting that Mcl-1 binding to Ku may release Ku from DSBs to initiate Mre11 complexmediated DNA resection leading to promotion of HR. The positive effect of Mcl-1 on DNA resection and HR accelerates the repair of DNA replication stress-induced DSBs. Selective promotion of HR-dependent DSB repair by Mcl-1 might play an important role in prolonging cell survival following DNA replication stress.
